Answers are grounded in this paper and cite their sources.
The development of a simple and sensitive immunoassay is crucial for achieving early disease diagnosis and effective treatment. Currently, immunological detection methods relying on signal amplification technology face significant technical challenges in terms of the sensitivity and accuracy of disease detection. Herein, we report a novel signal amplification technique based on a multifunctional dopamine-functionalized fluorescent probe (DFP) for enhancing the sensitivity of protein immunoassay. This DFP integrates the intrinsic chemical reactivity of dopamine with the signal-transduction capability of a fluorescent probe, enabling signal amplification through a dopamine-mediated cascade reaction. Crucially, in the target protein-triggered sandwich immunoassay system, horseradish peroxidase (HRP) conjugated to the detection antibody cooperates with Cu2+ to catalyze dopamine oxidation to form polydopamine, driving the in situ self-polymerization of the DFP and its simultaneous deposition onto the surface of the adjacent protein. The resulting polydopamine layer serves as a nanoscale scaffold that assembles multiple fluorophores, thereby dramatically enhancing fluorescence signal intensity and boosting assay sensitivity beyond that attainable with HRP-based detection alone. This method provides a wide linear range spanning four orders of magnitude, with detection limits of 0.38 pg/mL for alpha-fetoprotein and 0.92 pg/mL for carcinoembryonic antigen. Therefore, the HRP-Cu2+ cooperative catalysis-based signal amplification strategy combined with the DFP detection provides a versatile and highly promising technical platform for highly sensitive immunoassays and in vitro disease diagnosis.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: